日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial

一线治疗上皮性卵巢癌、输卵管癌或原发性腹膜癌的每周高剂量化疗(ICON8):一项开放标签、随机、对照的3期试验的总生存期结果

Clamp, Andrew R; James, Elizabeth C; McNeish, Iain A; Dean, Andrew; Kim, Jae-Won; O'Donnell, Dearbhaile M; Gallardo-Rincon, Dolores; Blagden, Sarah; Brenton, James; Perren, Tim J; Sundar, Sudha; Lord, Rosemary; Dark, Graham; Hall, Marcia; Banerjee, Susana; Glasspool, Rosalind M; Hanna, C Louise; Williams, Sarah; Scatchard, Kate M; Nam, Helena; Essapen, Sharadah; Parkinson, Christine; McAvan, Lucy; Swart, Ann Marie; Popoola, Babasola; Schiavone, Francesca; Badrock, Jonathan; Fananapazir, Fuad; Cook, Adrian D; Parmar, Mahesh; Kaplan, Richard; Ledermann, Jonathan A

Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial

一线新辅助卡铂-紫杉醇方案治疗卵巢癌、输卵管癌或原发性腹膜癌的客观疗效(ICON8):一项随机3期试验的事后探索性分析

Morgan, Robert D; McNeish, Iain A; Cook, Adrian D; James, Elizabeth C; Lord, Rosemary; Dark, Graham; Glasspool, Rosalind M; Krell, Jonathan; Parkinson, Christine; Poole, Christopher J; Hall, Marcia; Gallardo-Rincón, Dolores; Lockley, Michelle; Essapen, Sharadah; Summers, Jeff; Anand, Anjana; Zachariah, Abel; Williams, Sarah; Jones, Rachel; Scatchard, Kate; Walther, Axel; Kim, Jae-Weon; Sundar, Sudha; Jayson, Gordon C; Ledermann, Jonathan A; Clamp, Andrew R